Research graph
References from Systematic Review of Persistent Microscopic Hematuria and Kidney Outcomes in IgAN. Local targets link to admitted publications; unresolved targets remain external evidence.
IgA nephropathy
10.1056/nejmra1206793 · 2013 · External reference
AJKD Atlas of Renal Pathology: IgA nephropathy
10.1053/j.ajkd.2015.08.001 · 2015 · External reference
IgA nephropathy in adults: a review
10.1001/jama.2025.25020 · 2026 · External reference
Pathogenesis of glomerular haematuria
10.5527/wjn.v4.i2.185 · 2015 · External reference
The association of microhematuria with mesangial hypercellularity, endocapillary hypercellularity, crescent score and renal outcomes in immunoglobulin A nephropathy
10.1093/ndt/gfz267 · 2021 · External reference
Persistent microscopic hematuria as a risk factor for progression of IgA nephropathy: new floodlight on a nearly forgotten biomarker
10.1681/asn.2017060639 · 2017 · External reference
KDIGO 2025 clinical practice guideline for the management of immunoglobulin A nephropathy (IgAN) and immunoglobulin A vasculitis (IgAV)
10.1016/j.kint.2025.04.004 · 2025 · External reference
Microscopic hematuria as a risk factor for IgAN progression: considering this biomarker in selecting and monitoring patients
10.1093/ckj/sfad232 · 2023 · External reference
Persistent hematuria and kidney disease progression in IgA nephropathy: a cohort study
10.1053/j.ajkd.2019.11.008 · 2020 · External reference
Remission of hematuria improves renal survival in IgA nephropathy
10.1681/asn.2017010108 · 2017 · External reference
Hematuria as a biomarker guiding treatment decisions in IgA nephropathy? no
10.1093/ndt/gfag071 · 2026 · External reference
Hematuria as a biomarker guiding treatment decisions in IgA nephropathy? Yes
10.1093/ndt/gfag072 · 2026 · External reference
Kidney outcomes associated with haematuria and proteinuria trajectories among patients with IgA nephropathy in real-world clinical practice: the Japan Chronic Kidney Disease Database
10.1111/nep.14250 · 2024 · External reference
Renal survival and risk factors in IgA nephropathy with crescents
10.1007/s11255-020-02457-3 · 2020 · External reference
Time-averaged hematuria as a prognostic indicator of renal outcome in patients with IgA nephropathy
10.3390/jcm11226785 · 2022 · External reference
Clinical significance of persistent hematuria degrees in primary IgA nephropathy: a propensity score-matched analysis of a 10-year follow-up cohort
10.1159/000529650 · 2023 · External reference
Long-term renal survival and related risk factors in patients with IgA nephropathy: results from a cohort of 1155 cases in a Chinese adult population
10.1093/ndt/gfr527 · 2012 · External reference
Time-updated hematuria and kidney disease progression in IgAN
2026 · External reference
The approach to the patient with hematuria
10.1016/j.emc.2019.07.011 · 2019 · External reference
Prognosis in IgA nephropathy: 30-year analysis of 1,012 patients at a single center in Japan
10.1371/journal.pone.0091756 · 2014 · External reference
Treatment of IgA nephropathy: a rapidly evolving field
10.1681/asn.0000000000000242 · 2024 · External reference
The rapidly changing treatment landscape of IgA nephropathy
10.1016/j.semnephrol.2025.151573 · 2024 · External reference
Treatment of patients with IgA nephropathy: a call for a new paradigm
10.1016/j.kint.2025.01.014 · 2025 · External reference
Unresolved reference
External reference
Clinicopathological characteristics and prognostic factors of asymptomatic IgA nephropathy
10.2310/jim.0b013e3181d20aa1 · 2010 · External reference
Kidney functional reserve and damage biomarkers in subclinical chronic kidney disease and acute kidney injury
10.1152/ajprenal.00133.2023 · 2023 · External reference
Oxford Classification of IgA nephropathy 2016: an update from the IgA Nephropathy Classification Working Group
10.1016/j.kint.2017.02.003 · 2017 · External reference
The Oxford classification of IgA nephropathy: rationale, clinicopathological correlations, and classification
10.1038/ki.2009.243 · 2009 · External reference
Toronto Glomerulonephritis Registry. Remission of proteinuria improves prognosis in IgA nephropathy
10.1681/asn.2007050526 · 2007 · External reference
Microscopic hematuria in IgA nephropathy: a biomarker of disease activity
10.1093/ckj/sfag003 · 2026 · External reference
Tailored management strategies for IgA nephropathy based on clinical presentations
10.1093/ndt/gfae289 · 2025 · External reference
Haematuria increases progression of advanced proteinuric kidney disease
10.1371/journal.pone.0128575 · 2015 · External reference
Impact of hypertension and hypertension-related vascular lesions in IgA nephropathy
10.1291/hypres.29.15 · 2006 · External reference
Systolic blood pressure and chronic kidney disease progression in patients with primary glomerular disease
10.1007/s40620-020-00930-x · 2021 · External reference
Obesity, kidney dysfunction and hypertension: mechanistic links
10.1038/s41581-019-0145-4 · 2019 · External reference
Prognostic value of microscopic hematuria after induction of remission in antineutrophil cytoplasmic antibodies-associated vasculitis
10.1159/000500352 · 2019 · External reference
Lupus nephritis: redefining the treatment goals
10.1016/j.kint.2024.10.018 · 2025 · External reference
Hematuria and renal outcomes in patients with diabetic chronic kidney disease
10.1016/j.amjms.2018.06.005 · 2018 · External reference
Complement activation in IgA nephropathy
10.1007/s00281-021-00882-9 · 2021 · External reference
The pathophysiology of IgA nephropathy
10.1681/asn.2011050464 · 2011 · External reference
Role of serum complement C3 and C4 on kidney outcomes in IgA nephropathy
10.1038/s41598-024-65857-w · 2024 · External reference
Pathophysiology of IgA nephropathy
10.1097/pap.0000000000000134 · 2017 · External reference
Renal response to repetitive exposure to heme proteins: chronic injury induced by an acute insult
10.1046/j.1523-1755.2000.00101.x · 2000 · External reference
Podocytes are new cellular targets of haemoglobin-mediated renal damage
10.1002/path.5011 · 2018 · External reference
Glomerular hematuria: cause or consequence of renal inflammation?
10.3390/ijms20092205 · 2019 · External reference
Factors that determine an incomplete recovery of renal function in macrohematuria-induced acute renal failure of IgA nephropathy
10.2215/cjn.02670706 · 2007 · External reference
An expert opinion on current and future treatment approaches in IgA nephropathy
10.1007/s12325-025-03187-7 · 2025 · External reference
Long-term risk of ESRD in IgAN: validation of a Japanese prognostic model in a Norwegian cohort
10.1093/ndt/gfr446 · 2012 · External reference
Effect of hematuria on the outcome of immunoglobulin A nephropathy with proteinuria
10.15171/jnp.2016.12 · 2016 · External reference
Hematuria was a high risk for renal progression and ESRD in immunoglobulin A nephropathy: a systematic review and meta-analysis
10.1080/0886022x.2021.1879852 · 2021 · External reference
A phase 2b, randomized, double-blind, placebo-controlled, clinical trial of atacicept for treatment of IgA nephropathy
10.1016/j.kint.2024.03.012 · 2024 · External reference
Alternative complement pathway inhibition with iptacopan in IgA nephropathy
10.1056/nejmoa2410316 · 2025 · External reference
A phase 2 trial of sibeprenlimab in patients with IgA nephropathy
10.1056/nejmoa2305635 · 2024 · External reference
Laboratory reporting parameters of microhematuria: implications for interpreting the 2020 AUA guideline
10.1016/j.urology.2021.04.014 · 2021 · External reference
Glomerular hematuria and the utility of urine microscopy: a review
10.1053/j.ajkd.2022.02.022 · 2022 · External reference
Pitfalls in the diagnosis of hematuria
10.1515/cclm-2023-0260 · 2023 · External reference
